Page 1 of 1
Q.1
Which of the following is not a differential diagnosis for urticaria?
*
Eosinophilic dermatitis (Well’s syndrome)
Erythema multiforme-like drug eruption
Acute febrile neutrophilic dermatosis
Lupus erythematosus
Acute flare of atopic dermatitis
Trombidiosis
Plaque psoriasis
Q.2
Which endotype of CSU does the following statement best describe? “Mast cells are activated by IgE autoantibodies to autoallergens.”
*
Type I autoimmunity
Type IIb autoimmunity
Q.3
According to a recent study presented by Dr Sevdem Gulcan at EADV 2020, what effect does omalizumab have on risk of infection with COVID-19?
*
Increases risk
No effect on risk
Decreases risk
Q.4
According to the EACCI/GA2LEN/EDF/WAO guideline, how should treatment be escalated in patients with chronic urticaria who do not respond to treatment with standard-dose second-generation H1-antihistamines (sgAH) after 2–4 weeks?
*
Topical steroids (add-on to sgAH)
Omalizumab (add-on to sgAH)
Increase sgAH dose by up to 4X
Ciclosporin A (add-on to sgAH)
Q.5
Patients with urticaria are often affected by other atopic comorbidities
*
True
False
Page 1 of 1